4884 fundamentals
KRINGLE PHARMA INC revenue breakdown overview
KRINGLE PHARMA INC revenue for the last year amounted to 80.00 M JPY, the most of which — 73.84 M JPY — came from its highest performing source at the moment, Royalty, the year earlier bringing 69.25 M JPY. The greatest contribution to the revenue figure was made by United States — last year it brought KRINGLE PHARMA INC 80.04 M JPY, and the year before that — 69.25 M JPY.
By source
2020
2021
2022
2023
2024
0.00
120.00 M
240.00 M
360.00 M
480.00 M
Royalty
Drug Development
Currency: JPY
2020
2021
2022
2023
2024
Royalty
—
—
56.18 M
69.25 M
73.84 M
Drug Development
467.62 M
289.76 M
335.64 M
—
6.20 M
By country
2020
2021
2022
2023
2024
0.00
120.00 M
240.00 M
360.00 M
480.00 M
United States
Japan
Currency: JPY
2020
2021
2022
2023
2024
United States
167.62 M
289.76 M
391.83 M
69.25 M
80.04 M
Japan
300.00 M
—
—
—
—